Literature DB >> 17719101

Phosphatidylinositol 4,5-bisphosphate enhances store-operated calcium entry through hTRPC6 channel in human platelets.

Isaac Jardín1, Pedro C Redondo, Ginés M Salido, Juan A Rosado.   

Abstract

Phosphatidylinositol 4,5-bisphosphate (PIP2) is a versatile regulator of TRP channels. We report that inclusion of a PIP2 analogue, PIP2 1,2-dioctanoyl, does not induce non-capacitative Ca2+ entry per se but enhanced Ca2+ entry stimulated either by thrombin or by selective depletion of the Ca2+ stores in platelets, the dense tubular system, using 10 nM TG, and the acidic stores, using 20 microM 2,5-di-(tert-butyl)-1,4-hydroquinone (TBHQ). Reduction of PIP2 levels by blocking PIP2 resynthesis with Li+ or introducing a monoclonal anti-PIP2 antibody, or sequestering PIP2 using poly-lysine, attenuated Ca2+ entry induced by thrombin, TG and TBHQ, and reduced thrombin-evoked, but not TG- or TBHQ-induced, Ca2+ release from the stores. Incubation with the anti-hTRPC1 antibody did not alter the stimulation of Ca2+ entry by PIP2, whilst introduction of anti-hTRPC6 antibody directed towards the C-terminus of hTRPC6 reduced Ca2+ and Mn2+ entry induced by thrombin, TG or TBHQ, and abolished the stimulation of Ca2+ entry by PIP2. The anti-hTRPC6 antibody, but not the anti-hTRPC1 antibody or PIP2, reduced non-capacitative Ca2+ entry by the DAG analogue 1-oleoyl-2-acetyl-sn-glycerol. In summary, hTRPC6 plays a role both in store-operated and in non-capacitative Ca2+ entry. PIP2 enhances store-operated Ca2+ entry in human platelets, most probably by stimulation of hTRPC6 channels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719101     DOI: 10.1016/j.bbamcr.2007.07.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

Review 1.  Canonical transient receptor potential channels in diabetes.

Authors:  Sarabeth Graham; Joseph P Yuan; Rong Ma
Journal:  Exp Biol Med (Maywood)       Date:  2012-01-26

2.  R93W mutation in Orai1 causes impaired calcium influx in platelets.

Authors:  Wolfgang Bergmeier; Masatsugu Oh-Hora; Christie-Ann McCarl; R Claire Roden; Paul F Bray; Stefan Feske
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

3.  Ryanodine and IP3 receptor-mediated calcium signaling play a pivotal role in neurological infrared laser modulation.

Authors:  Gleb P Tolstykh; Cory A Olsovsky; Bennett L Ibey; Hope T Beier
Journal:  Neurophotonics       Date:  2017-04-05       Impact factor: 3.593

4.  Effects of protease-activated receptors (PARs) on intracellular calcium dynamics of acinar cells in rat lacrimal glands.

Authors:  Makoto Oikawa; Tomoyuki Saino; Katsura Kimura; Yuki Kamada; Yasunori Tamagawa; Daijiro Kurosaka; Yoh-ichi Satoh
Journal:  Histochem Cell Biol       Date:  2013-03-06       Impact factor: 4.304

Review 5.  Channelopathies linked to plasma membrane phosphoinositides.

Authors:  Diomedes E Logothetis; Vasileios I Petrou; Scott K Adney; Rahul Mahajan
Journal:  Pflugers Arch       Date:  2010-04-16       Impact factor: 3.657

6.  Proteins Interacting with STIM1 and Store-Operated Ca2+ Entry.

Authors:  Wen-An Wang; Nicolas Demaurex
Journal:  Prog Mol Subcell Biol       Date:  2021

7.  Local daily temperatures, thermal seasons, and suicide rates in Finland from 1974 to 2010.

Authors:  Laura Hiltunen; Jari Haukka; Reija Ruuhela; Kirsi Suominen; Timo Partonen
Journal:  Environ Health Prev Med       Date:  2014-05-03       Impact factor: 3.674

8.  Role of phosphoinositides in STIM1 dynamics and store-operated calcium entry.

Authors:  Ciara M Walsh; Michael Chvanov; Lee P Haynes; Ole H Petersen; Alexei V Tepikin; Robert D Burgoyne
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

Review 9.  Phosphoinositide regulation of TRP channels.

Authors:  Tibor Rohacs
Journal:  Handb Exp Pharmacol       Date:  2014

Review 10.  Phospholipase C mediated modulation of TRPV1 channels.

Authors:  Tibor Rohacs; Baskaran Thyagarajan; Viktor Lukacs
Journal:  Mol Neurobiol       Date:  2008-06-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.